Arlington Capital Partners, a private investment firm specializing in government-regulated industries, announced the final close of Arlington Capital Partners VII (ACP VII) with $6 billion in capital commitments. The fund was significantly oversubscribed, reaching its hard cap in less than five months and exceeding its $4.75 billion target. The close marks a 57% increase over Arlington’s prior fund, ACP VI, which closed in 2023, and a more than 250% increase over ACP V, which closed in 2019. 

Washington, D.C.-based Arlington invests in companies operating in aerospace and defense, government services and technology, and healthcare. 

“The investment landscape for our firm has never been more compelling,” said Managing Partners Matt Altman, Michael Lustbader, Peter Manos, and David Wodlinger. “Increasing domestic and international budgets for national security, the revitalization of U.S. manufacturing, and the expansion of government software and tech-enabled services are driving increased demand for the mission-critical companies that we build.” 

Since its founding in 1999, Arlington has completed approximately 200 investments across its core focus areas and has deployed more than $1 billion across 35 investments since the start of 2024. The firm has also achieved several notable exits, including the recent sale of BlueHalo to AV, creating a leading global defense technology company. 

Evercore served as Arlington’s exclusive global placement agent, while Simpson Thacher & Bartlett LLP acted as fund counsel.